In:
Pathobiology, S. Karger AG, Vol. 69, No. 2 ( 2001), p. 67-76
Kurzfassung:
〈 i 〉 Introduction: 〈 /i 〉 Genetic alterations of oncogene MDM2 promote malignant transformation of several human tumors. In tumors of the salivary gland, however, the genetic status of MDM2 has not been evaluated so far. 〈 i 〉 Methods and Results: 〈 /i 〉 Benign and malignant tumors of the salivary gland (6 pleomorphic adenomas, 3 Warthin’s tumors, 1 adenocarcinoma, 1 basal cell adenocarcinoma, 1 mucoepidermoid carcinoma, 3 acinic cell carcinomas, 2 adenoid cystic carcinoma, 1 squamous cell carcinoma) were analyzed by fluorescence-based PCR techniques and immunochemistry for MDM2 gene amplification, MDM2 gene expression, MDM2 gene mutation, MDM2 RNA splicing and MDM2 accumulation. Data show that all samples contained nonamplified MDM2 genes with nonmutant zinc finger regions. However, in two benign and two malignant samples, novel MDM2 mRNA splicing variant types 1 and 2 were detected. Furthermore, three malignant tumors revealed significant nuclear MDM2 accumulation. Correlation between levels of MDM2 mRNA and MDM2 protein could not be detected in the specimens. 〈 i 〉 Conclusion: 〈 /i 〉 The present study suggests that MDM2 gene mutation and gene amplification do not contribute to MDM2 accumulation detected in malignant tumors of the salivary gland. However, the role of novel MDM2 splicing variants in MDM2 expression and malignant transformation must be elucidated further.
Materialart:
Online-Ressource
ISSN:
1015-2008
,
1423-0291
Sprache:
Englisch
Verlag:
S. Karger AG
Publikationsdatum:
2001
ZDB Id:
1483541-1
SSG:
12
